Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome

Metabolic syndrome: a sympathetic disease?

(2015) Markus Schlaich et al.   Lancet Diabetes & Endocrinology

Role of leptin and central nervous system melanocortins in obesity hypertension

(2013) Alexandre A. da Silva et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Experimental Hyperleptinemia Acutely Increases Vasoconstrictory Sympathetic Nerve Activity in Healthy Humans

(2013) Felix Machleidt et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Leptin in nucleus of the solitary tract alters the cardiovascular responses to aortic baroreceptor activation

(2013) John Ciriello   PEPTIDES

Improved Hypertension Control with the Imidazoline Agonist Moxonidine in a Multinational Metabolic Syndrome Population: Principal Results of the MERSY Study

(2013) Irina Chazova et al.   International Journal of Hypertension

Neuroadrenergic Dysfunction Along the Diabetes Continuum: A Comparative Study in Obese Metabolic Syndrome Subjects

(2012) N. E. Straznicky et al.   DIABETES

Substantial Reduction in Single Sympathetic Nerve Firing After Renal Denervation in Patients With Resistant Hypertension

(2012) Dagmara Hering et al.   HYPERTENSION

Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension

(2011) Felix Mahfoud et al.   CIRCULATION

Effects of Renal Sympathetic Denervation on Blood Pressure, Sleep Apnea Course, and Glycemic Control in Patients With Resistant Hypertension and Sleep Apnea

(2011) Adam Witkowski et al.   HYPERTENSION

Renal denervation: a potential new treatment modality for polycystic ovary syndrome?

(2011) Markus P Schlaich et al.   JOURNAL OF HYPERTENSION

Insulin acts in the arcuate nucleus to increase lumbar sympathetic nerve activity and baroreflex function in rats

(2011) Priscila A. Cassaglia et al.   JOURNAL OF PHYSIOLOGY-LONDON

Sympathetic and haemodynamic responses to lipids in healthy human ageing

(2010) John P. Florian et al.   EXPERIMENTAL PHYSIOLOGY

Sympathetic nervous activation in obesity and the metabolic syndrome—Causes, consequences and therapeutic implications

(2010) Gavin W. Lambert et al.   PHARMACOLOGY & THERAPEUTICS

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

Sympathetic Neural Adaptation to Hypocaloric Diet With or Without Exercise Training in Obese Metabolic Syndrome Subjects

(2009) N. E. Straznicky et al.   DIABETES

Weight Loss May Reverse Blunted Sympathetic Neural Responsiveness to Glucose Ingestion in Obese Subjects With Metabolic Syndrome

(2009) N. E. Straznicky et al.   DIABETES

Diagnosis and Classification of Diabetes Mellitus

(2009)   DIABETES CARE

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

(2009) Henry Krum et al.   LANCET

Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome

(2008) Nora E Straznicky et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Mediators of sympathetic activation in metabolic syndrome obesity

(2008) Nora E. Straznicky et al.   CURRENT HYPERTENSION REPORTS

Central sympatholytic therapy has anti-inflammatory properties in hypertensive postmenopausal women

(2008) Maritta K Pöyhönen-Alho et al.   JOURNAL OF HYPERTENSION

Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study

(2008) Arnljot Flaa et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Mechanisms of Leptin Action and Leptin Resistance

(2007) Martin G. Myers et al.   Annual Review of Physiology